Uniseed Investee ENA Respiratory seeks participants for promising Australian COVID-19 preventative nasal spray – Sydney Phase I clinical trial
First-in-class, fast-acting nasal spray designed to boost innate immunity against respiratory viruses including COVID-19, influenza and the common cold, seeks participants for first in-human safety trial in Sydney
Last week Uniseed announced its investment in Currus Biologics, a Melbourne-based cancer biotech start-up working to improve the success of CAR-T cell therapies against solid tumours, representing the 60th investment completed by the Uniseed fund since it was formed in late 2000.
$10m invested into start-up developing new treatments targeting the use of CAR-T cell therapies against solid tumours
Currus Biologics, a Melbourne-based cancer biotech start-up, has completed an AU$10 million investment round to improve the success of CAR-T cell therapies against solid tumours such as breast, ovarian and pancreatic cancers.
Uniseed Investee ENA Respiratory Advances COVID-19 Preventative Therapy through AU$32 Million Fund Raise
ENA Respiratory Advances COVID-19 Preventative Therapy through AU$32 Million Fund Raise
– Round jointly led by Brandon Capital and Minderoo Foundation with co-investment from Uniseed will support the clinical development of INNA-051
– Company appoints President and Chief Scientific Officer of the COPD Foundation and respiratory therapy expert Ruth Tal-Singer, Ph.D. to Board of Directors
Uniseed is seeking an Investment Intern to join our team … a tremendous opportunity for a recent graduate to gain exposure to all aspects of the operation of a venture capital fund.
Industry and wholesale investors can now invest in the fast-tracking of Australian university and CSIRO research; enabling every Australian to support world-changing ideas.
BT Imaging Founder Professor Thorsten Trupke to receive prestigious international photovoltaic industry award
BT Imaging Founder Professor Thorsten Trupke to receive prestigious international photovoltaic industry award Uniseed congratulates Professor Thorsten Trupke, Founder of Uniseed investee BT Imaging, who will be honored by the international scientific and...
Uniseed Investee Exonate announces the initiation of Phase Ib/II clinical trial for Diabetic Macular Oedema
First patient dosed with an investigational retinal vascular disease eye drop
Uniseed Investee Kinoxis Completes $5M Financing Round and Advances Lead Program Through Key Toxicology Studies
Kinoxis Therapeutics Pty Ltd, a pre-clinical stage biotechnology company developing novel therapies for substance use disorders and other central nervous system disorders, has completed a funding round of $5m to enable continued development of the company’s development programs.
Research on preventative nasal spray, which protects against COVID-19 and common cold, published in leading peer reviewed academic journals
Research on preventative COVID-19 nasal spray published in prestigious, peer-reviewed academic journals: EBioMedicine and the European Respiratory Journal